EVALUATING THE PREDICTIVE VALUE OF TROPONIN I LEVELS IN ANTICIPATING ACUTE HEART FAILURE RISK AFTER NON-CARDIAC SURGICAL PROCEDURES
Main Article Content
Abstract
Objective: The objective of this study is to examine the correlation between Troponin I levels and perioperative cardiovascular incidents in medium to high risk patients undergoing non-cardiac surgical procedures at Vinh Phuc Provincial General Hospital. Methods: A cross-sectional descriptive study involving 100 patients scheduled for non-cardiac surgery was performed at Vinh Phuc Provincial General Hospital between October 2023 and September 2024. Troponin I levels were measured preoperatively, on postoperative day 1, and again on postoperative day 3. To evaluate the relationship between biomarker levels and perioperative outcomes occurring within 30 days post-surgery, logistic regression analysis was employed. Results: In a cohort of 100 patients with a mean age of 70 ± 12.6 years, 54% of the participants were female. Troponin I concentrations measured preoperatively, on postoperative day 1, and on postoperative day 3 were recorded as 0.02 ± 0.065 ng/ml, 0.014 ± 0.017 ng/ml, and 0,035 ± 0,129 ng/ml, respectively. Notably, Troponin I levels on day 3 exhibited a significant correlation with the incidence of acute heart failure, yielding an odds ratio of 30,077,121,790.7 (95% CI: 1.17 - 7.72880725607392E+20), with a p-value of 0.049. Conclusion: Troponin I is an important biomarker for assessing acute heart failure in patients undergoing non-cardiac surgery. Elevated levels indicate myocardial stress or injury, aiding in perioperative risk management.
Article Details
Keywords
non-cardiac surgery; acute heart failure; troponin I
References

2. Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43(39):3826-3924. doi:10.1093/eurheartj/ehac270


3. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Can Med Assoc J. 2005;173(6):627-634. doi:10.1503/cmaj.050011


4. Gualandro DM, Puelacher C, Chew MS, et al. Acute heart failure after non‐cardiac surgery: incidence, phenotypes, determinants and outcomes. Eur J Heart Fail. 2023;25(3):347-357. doi:10.1002/ejhf.2773


5. Millán-Figueroa A, López-Navarro JM, Pérez-Díaz I, et al. Evaluation of Perioperative High-Sensitive Cardiac Troponin I as a Predictive Biomarker of Major Adverse Cardiovascular Events After Noncardiac Surgery. Rev Investig Clínica. 2020;72(2):1847. doi:10.24875/RIC.19002888


6. Borges FK, Duceppe E, Heels-Ansdell D, et al. High-sensitivity troponin I predicts major cardiovascular events after noncardiac surgery. Eur Heart J. 2020;41(Supplement_2): ehaa946.1675. doi:10.1093/ehjci/ehaa946.1675

